Clinical Indications and Who May Benefit Based on the preclinical literature and emerging clinical use patterns, BPC-157 is most commonly applied in the following areas: Tendon, ligament, and muscle injuries (sprains, partial tears, chronic tendinopathy) Post-surgical tissue healing and recovery acceleration Inflammatory bowel conditions (Crohns, ulcerative colitis, leaky gut syndromes) NSAID-induced gastric damage notably, BPC-157 counteracts aspirin- and ibuprofen-driven mucosal injury Neuropathy and nerve regeneration protocols Systemic inflammation and autoimmune flares Recovery from alcohol-related liver and gut damage It is also increasingly used as a component in broader peptide therapy protocols alongside BPC-157s companion compounds
See TB-500 and the Stack Builder
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring peptide renowned for its role in promoting deep, restorative sleep
,
Strains, chronic tension, trigger points, and muscle imbalances create pain patterns that can mimic more serious conditions
prior FDA approval history Limited advantage